Search
The evidence derived from the review will be used to inform the development of guidelines for the management of skin infections in resource-limited settings
Treatment success for scabies co-infection was lower than for impetigo overall, with a higher success seen in the co-trimoxazole group than benzylpenicillin
We report osteomyelitis incidence in indigenous children of northern Australia is amongst the highest reported in the world
The prevalence of group A streptococcal disease remains high among symptomatic individuals residing in Africa
These data highlight the importance of recognising Sporotrichosis in children outside an outbreak setting
The Australian National Healthy Skin Guideline summarises evidence-based treatment of impetigo, scabies and fungal infections in high burden settings
The Group A β-hemolytic Streptococcus pharyngeal carriage rates seen in Uganda (15.9%) are higher than the most recent pooled results globally, at 12%
Health service utilisation in this setting may be enhanced by improving general awareness of the significance of childhood skin infections
There is low coverage of the multivalent M protein vaccine in our setting, emphasizing the need to reformulate the vaccine to improve coverage
Skin infection burden in remote Aboriginal communities can be reduced by the See, Treat, Prevent (SToP skin sores and scabies) trial